BioLight Life Sciences Ltd. (TLV:BOLT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
370.60
+23.00 (6.62%)
Aug 3, 2026, 5:24 PM IDT

BioLight Life Sciences Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
323225243053
Market Cap Growth
24.47%25.69%4.99%-19.99%-42.70%53.43%
Enterprise Value
15111312512
Last Close Price
3.483.525.445.206.6111.54

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----137.74
PS Ratio
--115.64204.41478.5417539.14
PB Ratio
0.810.810.820.800.560.86
P/TBV Ratio
0.940.940.970.830.570.87

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--58.93104.0286.874057.47

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.020.000.010.01
Net Debt / Equity Ratio
-0.55-0.55-0.42-0.28-0.32-0.54
Net Debt / EBITDA Ratio
1.431.431.280.851.763.30
Net Debt / FCF Ratio
2.002.001.170.781.793.13
Asset Turnover
--0.010.000.000
Quick Ratio
11.2111.216.523.736.9515.25
Current Ratio
12.1912.196.943.917.1115.38
Return on Equity (ROE)
-48.42%-48.42%-27.60%-65.45%-15.09%-0.56%
Return on Assets (ROA)
-24.84%-24.84%-18.71%-14.72%-10.65%-10.27%
Return on Invested Capital (ROIC)
-89.80%-86.12%-51.07%-36.51%-31.89%-55.70%
Return on Capital Employed (ROCE)
-37.60%-37.60%-31.60%-34.20%-18.90%-17.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-37.16%-36.84%-28.20%-107.88%-26.03%0.73%
FCF Yield
-34.41%-34.12%-43.52%-45.57%-31.75%-20.20%
Buyback Yield / Dilution
-27.27%-27.27%-0.29%-1.70%0.41%-0.94%